Evidence-Based Medicine Guidelines
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Pilocarpine for the Treatment of Salivary Gland Dysfunction Due to Radiotherapy." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy.
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy. Accessed April 21, 2025.
Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy
Oral Pilocarpine for the Treatment of Salivary Gland Dysfunction Due to Radiotherapy [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral pilocarpine for the treatment of salivary gland dysfunction due to radiotherapy
ID - 456503
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456503/all/Oral_pilocarpine_for_the_treatment_of_salivary_gland_dysfunction_due_to_radiotherapy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
